The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products
Active Pharmaceutical Ingredients
Contract development and manufacturing organisation (CDMO) Ardena, headquartered in Belgium, has acquired ChemConnection, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines.
Polypeptide Therapeutic Solutions and PMC Isochem (both headquartered in France) signed a business and technology collaboration agreement in the field of cosmetic and therapeutic polypeptide.
Enviero progesterone is produced by a first-of-its-kind progesterone synthesis developed by Pfizer that reduces waste, greenhouse gas emissions and use of hazardous solvents.
AXIM Biotechnologies announced the successful execution of proprietary cGMP methods to extract and microencapsulate cannabinoid molecules for a variety of pharmaceutical delivery formats from cGMP-produced medicinal cannabis.
Lonza, a Swiss chemicals and biotechnology, company announced the expansion of its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in USA.
Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient manufacturing company, announced that its Vionnaz site has successfully completed a Swissmedic inspection